Addressing the Global Problem of Antimicrobial Resistance

www.niaid.nih.gov/topics/antimicrobialResistance/Documents/ARstrategicplan2014.pdf

Leading Research to Understand, Treat, and Prevent Infectious, Immunologic, and Allergic Diseases

Visit us on the Web

Antimicrobial resistance has become a global crisis. In the U.S. alone, drug-resistant infections cause roughly 23,000 deaths a year, and the supply of new antibiotics has dwindled. In a commentary in JAMA this week, NIAID Director Anthony S. Fauci, M.D., along with colleague Hilary D. Marston, M.D., M.P.H., examine the problem and highlight how NIAID has recently adjusted its antimicrobial research efforts to apply innovative approaches to basic, clinical and translational research to address the problem.

To read the JAMA commentary, see: http://jama.jamanetwork.com/article.aspx?articleid=1851734.

Read about NIAID's refocused antimicrobial resistance research in the report, NIAID's Antimicrobial Resistance Program: Current Status and Future Directions, 2014.